S183: PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

• Phillip Scheinberg,
• Diego Cle,
• John Edwards,
• Valentina Giai,
• Marek Hus,
• Jin Seok Kim,
• Cristina Barrenetxea Lekue,
• Zsolt Nagy,
• Erfan Nur,
• Jens Panse,
• Yasutaka Ueda,
• Mustafa Nuri Yenerel,
• Anita Appius,
• Nadiesh Balachandran,
• Sammy Chebon,
• Brittany Gentile,
• Simon Buatois,
• Austin Kulasekararaj

Affiliations

Phillip Scheinberg

1 Hospital A, Beneficência Portuguesa, Division of Hematology, São Paulo, Brazil

Diego Cle

2 University of São Paulo, Ribeirão Preto School of Medicine, São Paulo, Brazil

John Edwards

3 Indiana Blood and Marrow Transplantation, Indianapolis, IN, United States

Valentina Giai

4 AOU Città della Salute e della Scienza di Torino, Department of Hematology and Oncology, Turin

Marek Hus

5 Medical University of Lublin, Department of Hematooncology and Bone Marrow Transplantation, Lublin, Poland

Jin Seok Kim

6 Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Rep. of South

Cristina Barrenetxea Lekue

7 Hospital Universitario de Basurto, Bilbao, Spain

Zsolt Nagy

8 Semmelweis University, Department of Internal Medicine, Budapest, Hungary

Erfan Nur

9 Amsterdam UMC, University of Amsterdam, Department of Hematology, Amsterdam, The Netherlands

Jens Panse

10 University Hospital RWTH Aachen, Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, Aachen, Germany

Yasutaka Ueda

11 Graduate School of Medicine, Faculty of Medicine, Osaka University, Department of Hematology and Oncology, Osaka, Japan

Mustafa Nuri Yenerel

12 Istanbul University University, Division of Hematology, Department of Internal Medicine, Istanbul, Turkey

Anita Appius

13 F. Hoffmann-La Roche, Ltd, Basel, Switzerland

Nadiesh Balachandran

14 F. Hoffmann-La Roche, Ltd, Welwyn Garden City, United Kingdom

Sammy Chebon

13 F. Hoffmann-La Roche, Ltd, Basel, Switzerland

Brittany Gentile

15 Genentech, Inc., San Francisco, CA, United States

Simon Buatois

13 F. Hoffmann-La Roche, Ltd, Basel, Switzerland

Austin Kulasekararaj

16 King’s College Hospital; National Institute for Health Research and Wellcome King’s Clinical Research Facility and King’s College London, Department of Haematological Medicine, London, United Kingdom